These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 419844)

  • 1. [Time differences between elevation of muscular oxygen tension and increase in painfree walking distance during treatment of severe intermittent claudication with ancrod].
    Ehrly AM; Köhler HJ; Schroeder W
    Vasa; 1979; 8(1):28-31. PubMed ID: 419844
    [No Abstract]   [Full Text] [Related]  

  • 2. [Effect of stepwise hypervolemic versus isovolemic hemodilution in patients with intermittent claudication on muscle oxygen pressure during exercise].
    Höffkes HG; Saeger-Lorenz K; Ehrly AM
    Vasa; 1991; 20(2):109-18. PubMed ID: 1877329
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of intermittent claudication: two different mechanisms.
    Linhart J; Vanĕk I
    Int Angiol; 1991; 10(1):6-9. PubMed ID: 2071977
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Therapeutic defibrinogenation by ancrod: effect on limb blood flow in peripheral vascular disease.
    Wiles PG; Nelson SR; Hampton KK; Casali B; Boothby M; Prentice CR
    Blood Coagul Fibrinolysis; 1990 Oct; 1(4-5):385-8. PubMed ID: 2133215
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of severe intermittent claudication by controlled defibrination.
    Dormandy JA; Goyle KB; Reid HL
    Lancet; 1977 Mar; 1(8012):625-6. PubMed ID: 66429
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Peripheral vasodilators versus pentoxifylline for the treatment of intermittent claudication.
    Aviado DM
    Ric Clin Lab; 1983; 13 Suppl 3():263-8. PubMed ID: 6143383
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oxygen pressure values in the ischemic muscle tissue of patients with chronic occlusive arterial disease.
    Ehrly AM; Schroeder W
    Adv Exp Med Biol; 1977 Jul 4-7; 94():401-5. PubMed ID: 613782
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intermittent intraarterial infusion therapy with PGE1 in patients with severe claudication--results of a randomized prospective double blind study.
    Caspary L; Creutzig A; Radeke U; Specht S; Alexander K
    Biomed Biochim Acta; 1988; 47(10-11):S307-10. PubMed ID: 3073766
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rapid foot and calf compression increases walking distance in patients with intermittent claudication: results of a randomized study.
    Ramaswami G; D'Ayala M; Hollier LH; Deutsch R; McElhinney AJ
    J Vasc Surg; 2005 May; 41(5):794-801. PubMed ID: 15886663
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Walking distance and arterial flow during long term treatment of intermittent claudication with d-a-tocopherol.
    Haeger K
    Vasa; 1973; 2(3):280-7. PubMed ID: 4745137
    [No Abstract]   [Full Text] [Related]  

  • 11. Treatment of intermittent claudication with pentoxifylline: a 12-month, randomized trial--walking distance and microcirculation.
    De Sanctis MT; Cesarone MR; Belcaro G; Nicolaides AN; Griffin M; Incandela L; Bucci M; Geroulakos G; Ramaswami G; Vasdekis S; Agus G; Bavera P; Ippolito E
    Angiology; 2002; 53 Suppl 1():S7-12. PubMed ID: 11865838
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Claudication distance is poorly estimated and inappropriately measured.
    Watson CJ; Phillips D; Hands L; Collin J
    Br J Surg; 1997 Aug; 84(8):1107-9. PubMed ID: 9278653
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ancrod: clinical indications and methods of use.
    Wright JG; Geroulakos G
    Semin Vasc Surg; 1996 Dec; 9(4):315-28. PubMed ID: 8958608
    [No Abstract]   [Full Text] [Related]  

  • 14. Levo-propionyl-carnitine improves the effectiveness of supervised physical training on the absolute claudication distance in patients with intermittent claudication.
    Andreozzi GM; Leone A; Laudani R; Martin R; Deinit G; Cataldi V
    Angiology; 2008; 59(1):84-9. PubMed ID: 18319227
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical evaluation of flunarizine: walking distance, ergometric performance, and hemodynamic and biochemical effects.
    Rudofsky G; Brock FE; Ulrich M; Nobbe F
    Angiology; 1979 Jul; 30(7):470-9. PubMed ID: 380410
    [No Abstract]   [Full Text] [Related]  

  • 16. [Padma-28, a herbal preparation, increases walking distance in patients with intermittent claudication].
    Drabaek H; Mehlsen J; Petersen JR; Himmelstrup H; Hansen KF
    Ugeskr Laeger; 1994 Oct; 156(42):6207-9. PubMed ID: 7998359
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Subcutaneous ancrod therapy in peripheral arterial disease: improvement in blood viscosity and nutritional blood flow.
    Lowe GD; Morrice JJ; Forbes CD; Prentice CR; Fulton AJ; Barbenel JC
    Angiology; 1979 Sep; 30(9):594-9. PubMed ID: 484913
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Heparan sulfate in the treatment of intermittent claudication: results of a randomized, double-blind, placebo-controlled multicenter trial.
    Messa GL; Gelso E
    Drugs Exp Clin Res; 2002; 28(1):37-48. PubMed ID: 12073766
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Comparison of the effectiveness of intra-arterial and intravenous administration of buflomedil in patients with intermittent claudication].
    Diehm C; Eckstein M; Hübsch-Müller C
    Vasa; 1989; 18(1):40-7. PubMed ID: 2648691
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of long-distance intermittent claudication with pentoxifylline: a 12-month, randomized trial.
    De Sanctis MT; Cesarone MR; Belcaro G; Nicolaides AN; Griffin M; Incandela L; Bucci M; Geroulakos G; Ramaswami G; Vasdekis S; Agus G; Bavera P; Ippolito E
    Angiology; 2002; 53 Suppl 1():S13-7. PubMed ID: 11865829
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.